120 related articles for article (PubMed ID: 38580566)
1. Tumour size predicts risk of recurrence in tall cell subtype papillary thyroid carcinoma.
Leong D; Leslie C; Laurie B; Hou L; Keyser J; Yew MK; Ryan S; Nguyen H; Lisewski D
Am J Surg; 2024 Mar; ():. PubMed ID: 38580566
[TBL] [Abstract][Full Text] [Related]
2. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
[TBL] [Abstract][Full Text] [Related]
3. Predicting tall-cell subtype of papillary thyroid carcinomas independently with preoperative multimodal ultrasound.
Ye BB; Liu YY; Zhang Y; Liu BJ; Guo LH; Wei Q; Zhang YF; Xu HX
Br J Radiol; 2024 Jun; 97(1159):1311-1319. PubMed ID: 38775639
[TBL] [Abstract][Full Text] [Related]
4. Papillary Thyroid Carcinomas with Tall Cell Features: An Intermediate Entity Between Classic and Tall Cell Subtypes.
Bikas A; Wong K; Pappa T; Ahmadi S; Wakefield CB; Marqusee E; Xiang P; Altshuler B; Haase J; Barletta JA; Landa I; Alexander EK
Thyroid; 2023 Jun; 33(6):697-704. PubMed ID: 36960703
[No Abstract] [Full Text] [Related]
5. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
[TBL] [Abstract][Full Text] [Related]
6. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients.
Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E
Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188
[TBL] [Abstract][Full Text] [Related]
7. Tall cell percentage alone in PTC without aggressive features should not guide patients' clinical management.
Poma AM; Viola D; Macerola E; Proietti A; Molinaro E; De Vietro D; Elisei R; Materazzi G; Miccoli P; Basolo F; Ugolini C
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4109-e4117. PubMed ID: 34061965
[TBL] [Abstract][Full Text] [Related]
8. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
[TBL] [Abstract][Full Text] [Related]
9. Diffuse Sclerosing Papillary Thyroid Carcinoma: Clinicopathological Characteristics and Prognostic Implications Compared with Classic and Tall Cell Papillary Thyroid Cancer.
Scholfield DW; Fitzgerald CW; Alzumaili B; Eagan A; Xu B; Martinez G; Tuttle RM; Shaha AR; Shah JP; Wong RJ; Patel SG; Ghossein RA; Ganly I
Ann Surg Oncol; 2023 Aug; 30(8):4761-4770. PubMed ID: 37154968
[TBL] [Abstract][Full Text] [Related]
10. Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma.
Xia F; Jiang B; Chen Y; Du X; Peng Y; Wang W; Wang Z; Li X
Medicine (Baltimore); 2018 Dec; 97(51):e13802. PubMed ID: 30572540
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Clinicopathological Characteristics and Short-Term Outcome of Papillary Thyroid Carcinoma with Tall Cell Histology and Classic Papillary Thyroid Carcinoma: A Single-Institution Experience.
Sampathkumar G; Nair V; Menon UV; Smitha NV; Sundaram S; Kumar H; Pavithran PV; Bhavani N; Menon AS; Abraham N; Pullikkal A
Indian J Endocrinol Metab; 2018; 22(3):405-409. PubMed ID: 30090735
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
[TBL] [Abstract][Full Text] [Related]
13. Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis.
Beom Heo D; Piao Y; Hee Lee J; Ju SH; Yi HS; Su Kim M; Won HR; Won Chang J; Seok Koo B; Eun Kang Y
Oral Oncol; 2022 Nov; 134():106115. PubMed ID: 36108524
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Arslan N; Emer O; Ince S; Deveci S; Ayan A; Taslipinar A; Gunalp B; Azal O
Nucl Med Commun; 2015 Oct; 36(10):1021-5. PubMed ID: 26225942
[TBL] [Abstract][Full Text] [Related]
15. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
16. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features and molecular characteristics of tall cell and hobnail variants of papillary thyroid carcinoma].
Zhang M; Duan HL; Wang LM; Gao W; Yao YY; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1234-1239. PubMed ID: 34719160
[No Abstract] [Full Text] [Related]
18. Surgical management of T1/T2 node-negative papillary thyroid cancer with tall cell histology: Is lobectomy enough?
Woods RSR; Fitzgerald CWR; Valero C; Lopez J; Morris LGT; Cohen MA; Wong RJ; Patel SG; Ghossein RA; Tuttle RM; Shaha AR; Shah JP; Ganly I
Surgery; 2023 Jan; 173(1):246-251. PubMed ID: 36257862
[TBL] [Abstract][Full Text] [Related]
19. A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma-How Much? How Tall? And When Is It Relevant?
Turchini J; Fuchs TL; Chou A; Sioson L; Clarkson A; Sheen A; Delbridge L; Glover A; Sywak M; Sidhu S; Gill AJ
Endocr Pathol; 2023 Dec; 34(4):461-470. PubMed ID: 37864666
[TBL] [Abstract][Full Text] [Related]
20. Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?
Calò PG; Pisano G; Medas F; Marcialis J; Gordini L; Erdas E; Nicolosi A
World J Surg Oncol; 2014 May; 12():152. PubMed ID: 24885654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
